217 related articles for article (PubMed ID: 36114932)
1. Non-cirrhotic portal hypertension (obliterative portal venopathy) is the predominant form of chronic liver disease in cystic fibrosis.
ONeill JP; Clifford CS; Nolan NP; McCormick PA
Ir J Med Sci; 2023 Aug; 192(4):1657-1660. PubMed ID: 36114932
[TBL] [Abstract][Full Text] [Related]
2. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
[TBL] [Abstract][Full Text] [Related]
3. Obliterative Portal Venopathy Without Cirrhosis Is Prevalent in Pediatric Cystic Fibrosis Liver Disease With Portal Hypertension.
Wu H; Vu M; Dhingra S; Ackah R; Goss JA; Rana A; Quintanilla N; Patel K; Leung DH
Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2134-2136. PubMed ID: 30404037
[TBL] [Abstract][Full Text] [Related]
4. Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis.
Ozturk NB; Fiel MI; Schiano TD
JGH Open; 2022 Sep; 6(9):607-611. PubMed ID: 36091322
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate.
Ibarrola C; Colina F
Histopathology; 2003 Mar; 42(3):251-64. PubMed ID: 12605645
[TBL] [Abstract][Full Text] [Related]
6. Obliterative portal venopathy without portal hypertension: an underestimated condition.
Guido M; Sarcognato S; Sonzogni A; Lucà MG; Senzolo M; Fagiuoli S; Ferrarese A; Pizzi M; Giacomelli L; Colloredo G
Liver Int; 2016 Mar; 36(3):454-60. PubMed ID: 26264219
[TBL] [Abstract][Full Text] [Related]
7. Pathology of idiopathic non-cirrhotic portal hypertension.
Guido M; Sarcognato S; Sacchi D; Colloredo G
Virchows Arch; 2018 Jul; 473(1):23-31. PubMed ID: 29644430
[TBL] [Abstract][Full Text] [Related]
8. Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.
Moctezuma-Velazquez C; Saffioti F; Tasayco-Huaman S; Casu S; Mason A; Roccarina D; Vargas V; Nilsson JE; Tsochatzis E; Augustin S; Montano-Loza AJ; Berzigotti A; Thorburn D; Genesca J; Abraldes JG
Am J Gastroenterol; 2019 Mar; 114(3):446-452. PubMed ID: 30315285
[TBL] [Abstract][Full Text] [Related]
9. Liver Explants of Biliary Atresia Patients Transplanted in Adulthood Show Features of Obliterative Portal Venopathy: Case Series and Guidelines for Pathologic Reporting of Adult Explants.
Patel KR; Dhingra S; Goss J
Arch Pathol Lab Med; 2023 Aug; 147(8):925-932. PubMed ID: 36343369
[TBL] [Abstract][Full Text] [Related]
10. Liver disease in cystic fibrosis presents as non-cirrhotic portal hypertension.
Witters P; Libbrecht L; Roskams T; De Boeck K; Dupont L; Proesmans M; Vermeulen F; Maleux G; Monbaliu D; Pirenne J; Cassiman D
J Cyst Fibros; 2017 Sep; 16(5):e11-e13. PubMed ID: 28347603
[No Abstract] [Full Text] [Related]
11. Noninvasive Evaluation of Fibrosis and Portal Hypertension in Primary Biliary Cholangitis.
Corpechot C
Clin Liver Dis; 2022 Nov; 26(4):681-689. PubMed ID: 36270723
[TBL] [Abstract][Full Text] [Related]
12. Obliteration of portal venules contributes to portal hypertension in biliary cirrhosis.
Shan S; Zhao X; Wood-Trageser MA; Hu D; Liu L; Qi B; Jian J; Wang P; Lv W; Hu C
J Pathol; 2024 Jun; 263(2):178-189. PubMed ID: 38551075
[TBL] [Abstract][Full Text] [Related]
13. [Non-cirrhotic intrahepatic portal hypertension].
Capron JP
Rev Prat; 1990 Jun; 40(16):1473-8. PubMed ID: 2359946
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.
Sheth S; Shea JC; Bishop MD; Chopra S; Regan MM; Malmberg E; Walker C; Ricci R; Tsui LC; Durie PR; Zielenski J; Freedman SD
Hum Genet; 2003 Aug; 113(3):286-92. PubMed ID: 12783301
[TBL] [Abstract][Full Text] [Related]
15. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography.
Ben-Ari Z; Panagou M; Patch D; Bates S; Osman E; Pasi J; Burroughs A
J Hepatol; 1997 Mar; 26(3):554-9. PubMed ID: 9075662
[TBL] [Abstract][Full Text] [Related]
16. Noncirrhotic portal hypertension in primary biliary cholangitis with coexisting CREST syndrome.
Malkani KV; Jesudian AB; Luo JJ; Schonfeld EA
Clin Res Hepatol Gastroenterol; 2023 May; 47(5):102114. PubMed ID: 36967074
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune biliary diseases: primary biliary cholangitis and primary sclerosing cholangitis.
Sarcognato S; Sacchi D; Grillo F; Cazzagon N; Fabris L; Cadamuro M; Cataldo I; Covelli C; Mangia A; Guido M
Pathologica; 2021 Jun; 113(3):170-184. PubMed ID: 34294935
[TBL] [Abstract][Full Text] [Related]
18. Retrograde detection of the intrahepatic portal vein in primary biliary cirrhosis: is sinusoidal blockage the underlying pathophysiology?
Maruyama H; Kondo T; Sekimoto T; Takahashi M; Fujiwara K; Imazeki F; Yokosuka O
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):321-7. PubMed ID: 25563140
[TBL] [Abstract][Full Text] [Related]
19. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
[TBL] [Abstract][Full Text] [Related]
20. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
Rocha HC; Vilela EG
Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
